AGITATION
Clinical trials for AGITATION explained in plain language.
Never miss a new study
Get alerted when new AGITATION trials appear
Sign up with your email to follow new studies for AGITATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a synthetic cannabis drug soothe Alzheimer's agitation?
Symptom relief Recruiting nowThis study tests whether nabilone, a synthetic cannabinoid already approved for nausea, can safely reduce agitation in people with Alzheimer's disease. Agitation is common and distressing, and current treatments have limited effectiveness and side effects. About 112 participants …
Matched conditions: AGITATION
Phase: PHASE3 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Symptom relief
Last updated May 17, 2026 01:44 UTC
-
New pill could calm Alzheimer's agitation – trial underway
Symptom relief Recruiting nowThis study tests an experimental pill (BMS-986368) to see if it can safely reduce agitation in people with Alzheimer's disease. About 120 participants will receive either the drug or a placebo. The goal is to ease symptoms like restlessness and aggression, not to cure Alzheimer's…
Matched conditions: AGITATION
Phase: PHASE2 • Sponsor: Celgene • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
New patch could ease agitation in Alzheimer's patients
Symptom relief Recruiting nowThis study tests a medicated skin patch (dexmedetomidine) to see if it can reduce agitation in people with Alzheimer's dementia. About 150 participants living in care facilities will receive either the patch or a placebo for 96 hours. The goal is to measure changes in agitated be…
Matched conditions: AGITATION
Phase: PHASE2 • Sponsor: Teikoku Pharma USA, Inc. • Aim: Symptom relief
Last updated May 14, 2026 12:06 UTC
-
Hope for Alzheimer's agitation: new drug in Late-Stage trial
Symptom relief Recruiting nowThis study tests an experimental drug called masupirdine to see if it can safely reduce agitation in people with Alzheimer's dementia. About 375 participants will receive either the drug or a placebo. The goal is to improve quality of life by calming symptoms like aggression and …
Matched conditions: AGITATION
Phase: PHASE3 • Sponsor: Suven Life Sciences Limited • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC
-
Robotic seal PARO tested to soothe patients after major surgery
Symptom relief Recruiting nowThis study tests whether a robotic seal called PARO can help reduce agitation, anxiety, and pain in adults after visceral surgery. 300 participants will either use PARO or receive standard care. The robot responds to touch and voice to calm patients. The goal is to see if this fr…
Matched conditions: AGITATION
Phase: NA • Sponsor: Hannover Medical School • Aim: Symptom relief
Last updated May 11, 2026 20:54 UTC
-
New hope for Alzheimer's agitation: Long-Term safety trial launches
Symptom relief Recruiting nowThis study is for people with Alzheimer's disease who experience agitation and have already completed a related study. It tests the long-term safety of a drug called KarXT, which combines two medications to help calm agitation. About 600 participants will take the drug and be mon…
Matched conditions: AGITATION
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Symptom relief
Last updated May 11, 2026 20:40 UTC
-
New brain monitor could improve ICU sedation care
Knowledge-focused Recruiting nowThis study tests a new brain activity monitor in 100 ICU patients who are on breathing machines and sedatives. The monitor uses a simple forehead patch to track brain signals and see if it matches standard checks for sedation and delirium. The goal is to find a better way to moni…
Matched conditions: AGITATION
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated May 17, 2026 01:47 UTC